Potentially clinically relevant moderate risk combinations present in the study sample were prednisolone/hydrochlorothiazide or torasemide, amlodipine/simvastatin, prednisolone/ASA, levothyroxine-natrium/calcium, combinations with vitamin D and/or other drugs, and combination of oxycodone/pregabalin (Table 2)...